INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC

Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research(the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes).

With a 20-year commitment to education, collaboration, and leadership, ISPOR meetings, published resources, and facilitated discussions have evolved as the leading resources for health economics and outcomes research. Moreover, as an unbiased organization of 9,500 individual and student members from 114 countries, and over 8,700 affiliate members from our Regional Chapters, ISPOR members represent the entire field including research, academia, decision and policy makers, consultants, payers, patient representative groups, and others. ISPOR is a non-profit 501(c)(3) public organization for educational and scientific purposes, as defined by the US IRS.